Guardant Health insider gifts 800 company shares

Q: What did Guardant Health (GH) insider John G. Saia report in this Form 4?

John G. Saia reported a bona fide gift of 800 shares of Guardant Health common stock on 2026-08-10, changing the form of ownership and leaving him with 38,991 directly held shares afterward.

Q: How many Guardant Health (GH) shares did John G. Saia gift?

John G. Saia gifted 800 shares of Guardant Health common stock. The transaction was reported as a bona fide gift, with no price per share, and is described as a change in form of ownership to a donor-advised fund.

Q: How many Guardant Health (GH) shares does John G. Saia hold after the gift?

After the reported gift, John G. Saia directly holds 38,991 shares of Guardant Health common stock. This post-transaction balance reflects the charitable transfer of 800 shares to a donor-advised fund associated with the Saia Family Foundation.

Q: Was the Guardant Health (GH) transaction by John G. Saia a market sale or a gift?

The transaction was a bona fide gift, not a market sale. The filing lists transaction code G, describes it as a gift transfer, and reports a per-share price of $0.00, consistent with a charitable disposition.

Q: Where were the Guardant Health (GH) shares transferred in John G. Saia’s Form 4?

The 800 Guardant Health shares were gifted to a donor-advised fund within the Saia Family Foundation. The footnote explains this as a change in form of ownership due to the charitable gift to that donor-advised fund.

Q: Is John G. Saia’s Guardant Health (GH) gift under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as a plan for this transaction. It reports a single bona fide gift of 800 shares, with no indication that it was executed under a pre-arranged trading plan.

Guardant Health, Inc. executive John G. Saia, Chief Legal Officer, reported a bona fide gift of 800 shares of common stock on 2026-08-10.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Guardant Health, Inc. executive John G. Saia, Chief Legal Officer, reported a bona fide gift of 800 shares of common stock on 2026-08-10. The gift reflects a change in form of ownership due to a transfer to a donor-advised fund within the Saia Family Foundation. Following this charitable transfer, Saia directly holds 38,991 shares of Guardant Health common stock.

Insider Trade Summary

800 shares gifted

Gift 1 txn

Insider Saia John G.

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Gift	Common Stock ^F1	800	$0.00	$0.00

Holdings After Transaction: Common Stock — 38,991 shares (Direct)

Footnotes (1)

F1. Reflects changes in form of ownership due to gift of shares to a DAF in the Saia Family Foundation.

Key Figures

Shares gifted: 800 shares Price per share: $0.00 Shares held after transaction: 38,991 shares +1 more

4 metrics

Shares gifted 800 shares Bona fide gift of Guardant Health common stock on 2026-08-10

Price per share $0.00 Reported per-share value for the bona fide gift transaction

Shares held after transaction 38,991 shares Directly held Guardant Health common stock following the gift

Gift shares in summary 800 shares Total gift shares across all reported transactions in this filing

Key Terms

bona fide gift, donor-advised fund, change in form of ownership

3 terms

bona fide gift regulatory

"The transaction code description identifies the transfer as a bona fide gift."

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

donor-advised fund financial

"The footnote notes a gift of shares to a DAF in the Saia Family Foundation."

A donor-advised fund is a charitable giving account that lets an individual or family deposit cash, stock, or other assets now, get an immediate tax benefit, and then recommend grants to charities over time. Think of it like a private charitable bucket you control without running a charity yourself; investors care because it’s a tax-efficient way to give appreciated securities, can change when and how donated shares enter the market, and affects personal and corporate tax planning.

change in form of ownership regulatory

"Footnote explains the transaction reflects changes in form of ownership due to the gift."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Guardant Health (GH) insider John G. Saia report in this Form 4?

John G. Saia reported a bona fide gift of 800 shares of Guardant Health common stock on 2026-08-10, changing the form of ownership and leaving him with 38,991 directly held shares afterward.

How many Guardant Health (GH) shares did John G. Saia gift?

John G. Saia gifted 800 shares of Guardant Health common stock. The transaction was reported as a bona fide gift, with no price per share, and is described as a change in form of ownership to a donor-advised fund.

How many Guardant Health (GH) shares does John G. Saia hold after the gift?

After the reported gift, John G. Saia directly holds 38,991 shares of Guardant Health common stock. This post-transaction balance reflects the charitable transfer of 800 shares to a donor-advised fund associated with the Saia Family Foundation.

Was the Guardant Health (GH) transaction by John G. Saia a market sale or a gift?

The transaction was a bona fide gift, not a market sale. The filing lists transaction code G, describes it as a gift transfer, and reports a per-share price of $0.00, consistent with a charitable disposition.

Where were the Guardant Health (GH) shares transferred in John G. Saia’s Form 4?

The 800 Guardant Health shares were gifted to a donor-advised fund within the Saia Family Foundation. The footnote explains this as a change in form of ownership due to the charitable gift to that donor-advised fund.

Is John G. Saia’s Guardant Health (GH) gift under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as a plan for this transaction. It reports a single bona fide gift of 800 shares, with no indication that it was executed under a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/12/2026 - 06:19 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saia John G.

(Last)

(First)

(Middle)

3100 HANOVER STREET

(Street)

PALO ALTO

CALIFORNIA

94304

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/10/2026		G		800⁽¹⁾	D	$0	38,991	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects changes in form of ownership due to gift of shares to a DAF in the Saia Family Foundation.

Remarks:

	/s/ John G. Saia	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR